01—Abstract
Summary
Summary of the 8-K filed May 2, 2025. Cited figures are marked; the original filing is the authoritative source.
On May 2, 2025, Bunge Global SA (NYSE: BG) announced that its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), further extended the expiration date of its exchange offers and consent solicitations for four series of notes issued by Viterra Finance B.V.
(2026, 2027, 2031 and 2032 notes, totaling roughly $1.95 billiona of eligible principal). The expiration moved from May 5, 2025 to June 13, 2025, and may be extended further. These exchange offers are tied to Bunge's pending acquisition of Viterra, and BLFC indicates it will keep extending the deadline until the deal can close on or before the expiration date.
Bunge stated that the regulatory approval process is progressing and that it expects to close in the next several months. As of 5:00 a.m. on May 2, 2025, holders had validly tendered roughly 96% to 99% of each series: about $576.7 millionb of the 2026 notes (96.1%), $430.6 million of the 2027 notes (95.7%), $596.4 million of the 2031 notes (99.4%), and $288.2 million of the 2032 notes (96.1%). Consents from the September 2024 early deadline were sufficient to approve the proposed amendments, which would strip many covenants and events of default and release the Viterra and Viterra B.V. guarantees.
Those amendments become operative only at settlement, which is expected within two business days after the expiration date. For investors, the filing is mainly a procedural update, but it signals that the Viterra acquisition timeline has slipped beyond the original schedule.
The high tender rates suggest broad holder participation, and the consent-based changes will reduce protections for any Viterra notes that remain outstanding, which may reduce their liquidity. The filing does not disclose a new closing date, so investors should watch for antitrust approvals and further extension notices.
02—Key points
Key Highlights
- Expiration of Bunge's exchange offers for Viterra notes extended from May 5, 2025 to June 13, 2025, with further extensions possible if the Viterra acquisition has not closed.
- Exchange offers cover about $1.95 billion of new BLFC notes guaranteed by Bunge, offered in exchange for four series of Viterra Finance B.V. notes (2026, 2027, 2031, 2032) plus cash.
- Strong early participation: as of May 2, 2025, tenders represented 95.7% to 99.4% of each series, with the 2031 notes at 99.4% ($596.4 million tendered).
- Consents from September 2024 were sufficient to approve amendments that eliminate most covenants and events of default and release the Viterra and Viterra B.V. guarantees, effective only at settlement.
- The transaction is conditioned on the closing of Bunge's acquisition of Viterra, which still requires antitrust approvals; Bunge expects to close in the next several months.
- Remaining holders of non-exchanged Viterra notes face reduced liquidity and weaker protections once the amendments become operative.
03—Questions
Frequently Asked Questions
Why did Bunge extend the expiration date of the exchange offers?
The exchange offers are tied to Bunge's pending acquisition of Viterra. Because the acquisition has not yet closed and regulatory approvals are still in progress, BLFC extended the deadline from May 5 to June 13, 2025, and says it will keep extending it until the acquisition can close on or before the expiration date.
What do holders receive in the exchange offers?
Eligible holders can exchange their Viterra notes for new notes issued by BLFC and guaranteed by Bunge, up to $1.95 billion in aggregate principal, and for cash. The new Bunge notes have not been registered under the Securities Act.
What are the consent solicitations trying to accomplish?
The consent solicitations seek amendments to the Viterra indentures that would eliminate many covenants, restrictive provisions and events of default, and release the guarantees of Viterra and Viterra B.V. Consents were already sufficient as of September 2024, but the amendments become operative only at settlement.
What does this mean for investors holding Viterra notes that are not exchanged?
Non-exchanged holders will face reduced protection because the indenture covenants and guarantees will be stripped away once the amendments take effect. The filing also notes that these holders may experience reduced liquidity, since most of the outstanding notes are expected to be exchanged.
Has the Viterra acquisition closed, and when is it expected to?
No. As of this filing, the Viterra acquisition has not closed. Bunge says the regulatory approval process is progressing and that it expects to close in the next several months, but it does not provide a specific date.
04—Continue